HER2-Directed Antibody Drug Conjugates in Breast Cancer: Recent Progress and Future Opportunities
Time: 8:30 am
day: Conference Day One
Details:
For full session details, download the full event guide
Time: 8:30 am
day: Conference Day One
Details:
For full session details, download the full event guide